These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 34800218)
21. Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma. Gong WF; Zhong JH; Lu SD; Wang XB; Zhang QM; Ma L; Zhang ZM; Xiang BD; Li LQ Oncotarget; 2017 Feb; 8(9):15047-15056. PubMed ID: 28122361 [TBL] [Abstract][Full Text] [Related]
22. Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment. Kim JH; Sinn DH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW Hepatology; 2017 Aug; 66(2):335-343. PubMed ID: 28012257 [TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus DNA negativity acts as a favorable prognostic factor in hepatocellular carcinoma patients. Li X; Zhong X; Chen ZH; Xing YF; Wu DH; Chen J; Ma XK; Lin Q; Wen JY; Wei L; Wang TT; Ruan DY; Lin ZX; Wu XY; Dong M Asian Pac J Cancer Prev; 2014; 15(22):9635-41. PubMed ID: 25520081 [TBL] [Abstract][Full Text] [Related]
24. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma. Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455 [TBL] [Abstract][Full Text] [Related]
25. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients. Kim GA; Han S; Choi GH; Choi J; Lim YS Aliment Pharmacol Ther; 2020 Jun; 51(11):1169-1179. PubMed ID: 32291781 [TBL] [Abstract][Full Text] [Related]
26. Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients. Kim DS; Park SY; Kim BK; Park JY; Kim DY; Han KH; Lee YR; Tak WY; Kweon YO; Jung I; Han M; Kim EH; Ahn SH; Kim SU J Korean Med Sci; 2021 Apr; 36(16):e105. PubMed ID: 33904261 [TBL] [Abstract][Full Text] [Related]
27. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma. Huang L; Li J; Lau WY; Yan J; Zhou F; Liu C; Zhang X; Shen J; Wu M; Yan Y J Gastroenterol Hepatol; 2012 Jan; 27(1):158-64. PubMed ID: 21871026 [TBL] [Abstract][Full Text] [Related]
28. Association of Serum Hepatitis B Virus RNA With Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Under Nucleos(t)ide Analogues Therapy. Liu S; Deng R; Zhou B; Liang X; Liu Z; Peng J; Chen J; Zhou Y; Guo Y; Chen Y; Li W; Shen S; Lu X; Zhao S; Liao X; Liang H; Lan Y; Hou J; Fan R; Sun J J Infect Dis; 2022 Sep; 226(5):881-890. PubMed ID: 34931674 [TBL] [Abstract][Full Text] [Related]
29. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358 [TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics and survival analysis of patients with hepatocellular carcinoma after hepatitis B virus turning negative. Li H; Guo WM; Xie Q; Sun X; Wang Q Adv Clin Exp Med; 2022 Jul; 31(7):731-738. PubMed ID: 35302303 [TBL] [Abstract][Full Text] [Related]
31. Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinoma. Li C; Li ZC; Ma L; Li LQ; Zhong JH; Xiang BD; Gong WF Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):749-756. PubMed ID: 32552297 [TBL] [Abstract][Full Text] [Related]
32. Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity. Kim MN; Kim BK; Cho H; Goh MJ; Roh YH; Yu SJ; Sinn DH; Park SY; Kim SU PLoS One; 2024; 19(8):e0307712. PubMed ID: 39186715 [TBL] [Abstract][Full Text] [Related]
33. Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B. Choi WM; Kim GA; Choi J; Han S; Lim YS J Clin Invest; 2022 May; 132(10):. PubMed ID: 35358094 [TBL] [Abstract][Full Text] [Related]
34. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study. Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631 [TBL] [Abstract][Full Text] [Related]
35. Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis. Huang DQ; Tamaki N; Lee HW; Park SY; Lee YR; Lee HW; Lim SG; Lim TS; Kurosaki M; Marusawa H; Mashiba T; Kondo M; Uchida Y; Kobashi H; Furuta K; Izumi N; Kim BK; Sinn DH Hepatology; 2023 May; 77(5):1746-1756. PubMed ID: 36633913 [TBL] [Abstract][Full Text] [Related]
36. Risk factors for hepatitis B virus reactivation after conformal radiotherapy in patients with hepatocellular carcinoma. Huang W; Zhang W; Fan M; Lu Y; Zhang J; Li H; Li B Cancer Sci; 2014 Jun; 105(6):697-703. PubMed ID: 24654677 [TBL] [Abstract][Full Text] [Related]
37. Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma. Chong CC; Wong GL; Lai PB World J Gastroenterol; 2014 May; 20(20):6006-12. PubMed ID: 24876723 [TBL] [Abstract][Full Text] [Related]
38. Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. Lee PC; Chao Y; Chen MH; Lan KH; Lee IC; Hou MC; Huang YH J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32863270 [TBL] [Abstract][Full Text] [Related]
39. Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus. Lee JI; Kim JK; Chang HY; Lee JW; Kim JM; Chung HJ; Kim YS; Lee KS J Gastroenterol Hepatol; 2014 May; 29(5):1019-27. PubMed ID: 24325315 [TBL] [Abstract][Full Text] [Related]
40. Comparable Efficacy Between Ongoing Versus Initiation of Antiviral Therapy at Treatment for HBV-related Hepatocellular Carcinoma. Kim MN; Kim BK; Roh YH; Choi NR; Yu SJ; Kim SU Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1877-1880.e3. PubMed ID: 35181566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]